Huons gets KFDA approval for combination drug

Huons and CTC Bio said Tuesday that the Korea Food and Drug Administration has given the green light to Arigrel, which combines the two most commonly prescribed medicines, clopidogrel and aspirin, for the treatment of arteriosclerosis.

“Arigrel may ensure patient compliance as it can help reduce the number of pills patients have to take and they can follow their regimes faithfully,” a Huons ...